Literature DB >> 32615317

Gene signatures of SARS-CoV/SARS-CoV-2-infected ferret lungs in short- and long-term models.

Hsin-Liang Liu1, I-Jeng Yeh2, Nam Nhut Phan3, Yen-Hung Wu2, Meng-Chi Yen2, Jui-Hsiang Hung4, Chung-Chieh Chiao5, Chien-Fu Chen5, Zhengda Sun6, Jia-Zhen Jiang7, Hui-Ping Hsu8, Chih-Yang Wang9, Ming-Derg Lai10.   

Abstract

Coronaviruses (CoVs) consist of six strains, and the severe acute respiratory syndrome coronavirus (SARS-CoV), newly found coronavirus (SARS-CoV-2) has rapidly spread leading to a global outbreak. The ferret (Mustela putorius furo) serves as a useful animal model for studying SARS-CoV/SARS-CoV-2 infection and developing therapeutic strategies. A holistic approach for distinguishing differences in gene signatures during disease progression is lacking. The present study discovered gene expression profiles of short-term (3 days) and long-term (14 days) ferret models after SARS-CoV/SARS-CoV-2 infection using a bioinformatics approach. Through Gene Ontology (GO) and MetaCore analyses, we found that the development of stemness signaling was related to short-term SARS-CoV/SARS-CoV-2 infection. In contrast, pathways involving extracellular matrix and immune responses were associated with long-term SARS-CoV/SARS-CoV-2 infection. Some highly expressed genes in both short- and long-term models played a crucial role in the progression of SARS-CoV/SARS-CoV-2 infection, including DPP4, BMP2, NFIA, AXIN2, DAAM1, ZNF608, ME1, MGLL, LGR4, ABHD6, and ACADM. Meanwhile, we revealed that metabolic, glucocorticoid, and reactive oxygen species-associated networks were enriched in both short- and long-term infection models. The present study showed alterations in gene expressions from short-term to long-term SARS-CoV/SARS-CoV-2 infection. The current result provides an explanation of the pathophysiology for post-infectious sequelae and potential targets for treatment.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bioinformatics; Coronavirus; Ferret (Mustela putorius furo); SARS-CoV; SARS-CoV-2

Year:  2020        PMID: 32615317     DOI: 10.1016/j.meegid.2020.104438

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  21 in total

Review 1.  Natural and Experimental SARS-CoV-2 Infection in Domestic and Wild Animals.

Authors:  David A Meekins; Natasha N Gaudreault; Juergen A Richt
Journal:  Viruses       Date:  2021-10-04       Impact factor: 5.048

2.  Severe acute respiratory syndrome coronavirus (SARS-CoV)-2 infection induces dysregulation of immunity: in silico gene expression analysis.

Authors:  Yen-Hung Wu; I-Jeng Yeh; Nam Nhut Phan; Meng-Chi Yen; Hsin-Liang Liu; Chih-Yang Wang; Hui-Ping Hsu
Journal:  Int J Med Sci       Date:  2021-01-01       Impact factor: 3.738

3.  Novel signaling pathways regulate SARS-CoV and SARS-CoV-2 infectious disease.

Authors:  Li-Chin Cheng; Tzu-Jen Kao; Nam Nhut Phan; Chung-Chieh Chiao; Meng-Chi Yen; Chien-Fu Chen; Jui-Hsiang Hung; Jia-Zhen Jiang; Zhengda Sun; Chih-Yang Wang; Hui-Ping Hsu
Journal:  Medicine (Baltimore)       Date:  2021-02-19       Impact factor: 1.817

Review 4.  Harnessing CRISPR-Cas to Combat COVID-19: From Diagnostics to Therapeutics.

Authors:  Kok Gan Chan; Geik Yong Ang; Choo Yee Yu; Chan Yean Yean
Journal:  Life (Basel)       Date:  2021-11-09

5.  Gene signatures and potential therapeutic targets of Middle East respiratory syndrome coronavirus (MERS-CoV)-infected human lung adenocarcinoma epithelial cells.

Authors:  Yen-Hung Wu; I-Jeng Yeh; Nam Nhut Phan; Meng-Chi Yen; Jui-Hsiang Hung; Chung-Chieh Chiao; Chien-Fu Chen; Zhengda Sun; Hui-Ping Hsu; Chih-Yang Wang; Ming-Derg Lai
Journal:  J Microbiol Immunol Infect       Date:  2021-03-26       Impact factor: 4.399

6.  The multiple sclerosis (MS) drugs as a potential treatment of ARDS in COVID-19 patients.

Authors:  Malgorzata Kloc; Rafik M Ghobrial
Journal:  Mult Scler Relat Disord       Date:  2020-07-31       Impact factor: 4.339

Review 7.  Host factors facilitating SARS-CoV-2 virus infection and replication in the lungs.

Authors:  Sébastien Boutin; Dagmar Hildebrand; Steeve Boulant; Michael Kreuter; Jule Rüter; Srinivas Reddy Pallerla; Thirumalaisamy P Velavan; Dennis Nurjadi
Journal:  Cell Mol Life Sci       Date:  2021-07-05       Impact factor: 9.261

Review 8.  Current State of Knowledge about Role of Pets in Zoonotic Transmission of SARS-CoV-2.

Authors:  Mateusz Dróżdż; Paweł Krzyżek; Barbara Dudek; Sebastian Makuch; Adriana Janczura; Emil Paluch
Journal:  Viruses       Date:  2021-06-16       Impact factor: 5.048

Review 9.  Advanced CRISPR-Cas Effector Enzyme-Based Diagnostics for Infectious Diseases, Including COVID-19.

Authors:  Sangha Kwon; Ha Youn Shin
Journal:  Life (Basel)       Date:  2021-12-07

10.  Prognoses and genomic analyses of proteasome 26S subunit, ATPase (PSMC) family genes in clinical breast cancer.

Authors:  Tzu-Jen Kao; Chung-Che Wu; Nam Nhut Phan; Yen-Hsi Liu; Hoang Dang Khoa Ta; Gangga Anuraga; Yung-Fu Wu; Kuen-Haur Lee; Jian-Ying Chuang; Chih-Yang Wang
Journal:  Aging (Albany NY)       Date:  2021-07-30       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.